News

The results of vehicle-controlled, double-blind, randomised Phase 2b study support the advancement of Nexagon into Phase 3 registration trials. The UNC Limb Salvage/Wound Healing Center medical director and

The temporary arrangement is to address the present critical shortage of non-FDA approved Sodium Bicarbonate Injection, USP in the region. Sagent president, chief executive officer and board chairman

The COPD therapy, administered using the ELLIPTA inhaler, is a combination of GSK573719 or umeclidinium bromide (UMEC), a long-acting muscarinic antagonist (LAMA) and vilanterol (VI), a long-acting beta2

Galapagos CEO Onno van de Stolpe said the company has identified five candidate drugs of which two have been in-licensed by GSK to date, since the start of

ARGAMATE Granule is indicated for the treatment of hyperkalemia resulting from acute or chronic renal failure and it helps in withdrawing the unnecessary potassium in the gastrointestinal tract.

Aureus is involved in gathering high quality quantitative biological activity data of major therapeutic drugs, which enables researchers to identify the promising compounds, repurpose existing compounds as well

The ADC facility expansion is expected to double the present large-scale manufacturing capacity in Visp without interrupting the current operations. Lonza chemical manufacturing business unit head Stefan Stoffel

The research partnership will leverage first rate science performed at Yale University along with Evotec’s drug discovery infrastructure and knowledge. Evotec chief scientific officer Dr Cord Dohrmann said,

Grayling is involved in manufacturing various brands for the asbestos abatement and remediation industry including Avail glove bags, D-Con decontamination enclosures, and Control chemicals. The acquisition is expected